CLU and Alzheimer disease: The inflammatory component of AD is an area under intense study, and it is clear that glial responses to protein aggregation contribute to AD pathogenesis (Heneka et al., 2015); however, the potential neuro-inflammation regulatory role of clusterin in AD has not been studied in depth.